New formulation
Showing 1 - 25 of >10,000
Healty Volunteers, Preventable Disease, Vaccine Trial in Göteborg (Etvax)
Recruiting
- Healty Volunteers
- Preventable Disease, Vaccine
- Etvax
-
Göteborg, SwedenClinical Trial Center, CTC
Jan 4, 2022
Healthy Volunteers Trial (BMS-986419 DR Capsule, BMS-986419 IR Tablet)
Not yet recruiting
- Healthy Volunteers
- BMS-986419 DR Capsule
- BMS-986419 IR Tablet
- (no location specified)
Jul 20, 2023
Healthy Participants Trial in Cypress (Semaglutide J, Semaglutide C)
Recruiting
- Healthy Participants
- Semaglutide J
- Semaglutide C
-
Cypress, CaliforniaNovo Nordisk Investigational Site
Mar 28, 2023
Healthy Trial in Seoul (YH4808 NF 100, YH4808 OF 200, YH4808 NF 200)
Completed
- Healthy
- YH4808 NF 100
- +3 more
-
Seoul, Korea, Republic ofYonsei Medical Center Severance Hospital Clinical Trials Center
Dec 26, 2021
Healthy Trial in Biberach (BI 1810631 - trial formulation 1 (TF1), BI 1810631 - new formulation (NF), Rabeprazole sodium)
Completed
- Healthy
- BI 1810631 - trial formulation 1 (TF1)
- +2 more
-
Biberach, GermanyHumanpharmakologisches Zentrum Biberach
Sep 16, 2022
Acute Rhinosinusitis Trial in Faisalabad (Mometasone Nasal 50 Mcg/Inh Nasal Spray, Nasal spray)
Completed
- Acute Rhinosinusitis
- Mometasone Nasal 50 Mcg/Inh Nasal Spray
- Nasal spray
-
Faisalabad, Punjab, PakistanSaffron Pharmaceutical
Nov 27, 2022
Safety, Bioavailability, Pharmacokinetics Trial in Ljubljana (Linaprazan glurate)
Completed
- Safety
- +2 more
- Linaprazan glurate
-
Ljubljana, Ukmarjeva Ulica 6, SloveniaCRS d.o.o.
Jan 17, 2023
Coronavirus Disease Trial in Princeton
Completed
- Coronavirus Disease
-
Princeton, New JerseyGlobal Clinical Trials, LLC,
Mar 2, 2023
Healthy Volunteers, Type 2 Diabetes Trial in Berlin (Oral semaglutide)
Completed
- Healthy Volunteers
- Type 2 Diabetes
- Oral semaglutide
-
Berlin, GermanyNovo Nordisk Investigational Site
Sep 27, 2021
Wilson's Disease Trial in London (900mg TETA 4HCl Once Daily Formulation, 900mg TETA 4HCl Cuprior®)
Not yet recruiting
- Wilson's Disease
- 900mg TETA 4HCl Once Daily Formulation
- 900mg TETA 4HCl Cuprior®
-
London, United KingdomRichmond Pharmacology Ltd
Nov 7, 2023
Healthy Participants Trial in Montreal (Semaglutide)
Recruiting
- Healthy Participants
-
Montreal, Quebec, CanadaNovo Nordisk Investigational Site
Oct 18, 2023
Healthy Subjects Trial in Groningen (Apraglutide)
Recruiting
- Healthy Subjects
-
Groningen, NetherlandsICON Clinical Research Unit
Aug 15, 2023
Hypertension Trial in Cincinnati (baxdrostat (formerly CIN-107) oral solution)
Completed
- Hypertension
- baxdrostat (formerly CIN-107) oral solution
-
Cincinnati, OhioMedpace
Jul 18, 2023
Healthy Trial in New Haven (Encorafenib capsule formulation (CAP), Encorafenib first formulation, Encorafenib second
Completed
- Healthy
- Encorafenib capsule formulation (CAP)
- +3 more
-
New Haven, ConnecticutNew Haven Clinical Research Unit
Nov 2, 2022
Clostridoides Difficile Associated Disease Trial in United States (C. difficile vaccine (previously studied formulation), C.
Recruiting
- Clostridoides Difficile Associated Disease
- C. difficile vaccine (previously studied formulation)
- +4 more
-
Anaheim, California
- +8 more
Apr 6, 2023
Healthy Trial in New Haven (Single dose of PF-07104091 as Tablet Formulation A (Treatment A), Single dose of PF-07104091 as
Recruiting
- Healthy
- Single dose of PF-07104091 as Tablet Formulation A (Treatment A)
- +4 more
-
New Haven, ConnecticutNew Haven Clinical Research Unit
Jun 21, 2022
Healthy Trial in New Haven (PF-06821497 Treatment A, PF-06821497 Treatment B, PF-06821497 Treatment C)
Not yet recruiting
- Healthy
- PF-06821497 Treatment A
- +5 more
-
New Haven, ConnecticutNew Haven Clinical Research Unit
Mar 17, 2023